‘StorPharma LLP” is a dynamically developing international pharmaceutical company founded in 2016 by pharmaceutical professionals who are experienced more than 10 years of extensive knowledge of Distribution, Sales and Marketing. Our talented founders accordingly embraced the company’s culture and considered necessary to move the company forward to greater accountability and sustainable success due to their huge experience on different positions in many of the multinational pharmaceutical companies.
The main activity is the development and launch of unique combinations of known components to the pharmaceutical market. The company is represented in the countries of Europe, CIS and Central Asia. STORPharma LLP products have registration certificates and meet EurAsEC requirements. Currently, the company’s portfolio includes more than 20 names of medicines and biologically active additives.
Our mission to be a leading international pharmaceutical company and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment.
The global footprint of our company includes new product research and marketing strategy and oversight. We will discover, develop and successfully market pharmaceutical products to prevent, diagnose, alleviate and cure diseases. We shall provide total customer satisfaction and achieve leadership in chosen markets, products and services across the globe, through excellence in quality, technology, based on world-class research and development and highly skilled staff. We are responsible to the society. We shall be good corporate citizens and will be driven by high ethical standards in our practices. By the end of 2023, STOR PharmA will expand its coverage to 15 countries via a robust sales structure which covers 3 countries for today.